Hong Kong's legislature approved the biggest overhaul of its political system in the quarter century since British rule on Thursday, in a decisive step to assert Beijing's authority over the autonomous city.
Valerie Volcovici
1/3
EPA Administrator Michael Regan delivers remarks on American Economic Recovery at Guilford Technical Community College in Greensboro, North Carolina, U.S., April 19, 2021. REUTERS/Tom Brenner/File Photo
Read More
The U.S. Environmental Protection Agency on Thursday said it will revise a rule issued by the former Trump administration nearly a year ago that limited state powers to use the federal clean water permitting process to block energy infrastructure projects amid concerns about climate change.
EPA Administrator Michael Regan on Thursday said the agency will revise the 2020 Clean Water Act (CWA) Section 401 Certification Rule issued by his predecessor Andrew Wheeler in June 2020 after deciding that it eroded state and Tribal authority to protect their water resources.
Reuters
2 minute read
The logo of Gilead Sciences Inc pharmaceutical company is seen in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo/File Photo
Russia s Supreme Court on Thursday rejected a lawsuit from U.S. company Gilead Sciences (GILD.O)that challengeda Russian government decision to let a Russian firm develop and market the anti-COVID-19 drug remdesivir without Gilead s consent.
The Russian government late last year granted Russian drugmaker Pharmasyntez a compulsory licence for one year to manufacture the drug under a different name without Gilead s permission.
The government said in a decree at the time that the move was in the interests of Russia s own security. According to the decree, Russia had to pay compensation to the drug s patent-holder. The amount was not specified.
Brahim Ghali, the leader of Western Sahara's independence movement Polisario Front, whose presence in Spain has angered Morocco, will attend a high court hearing remotely next Tuesday from hospital, his lawyer's office said on Thursday.
Bayer (BAYGn.DE) said on Thursday it was not increasing its $2 billion in provisions after a U.S. judge rejected its class action plan to settle future claims related to its Roundup and other glyphosate-based weedkillers.